What is the FDA approval status of MIRM.

The FDA approval status of MIRM is currently pending. The PDUFA (Prescription Drug User Fee Act) date is set for March 13, 2024, and the indication for the drug is Liver disease, Progressive familial intrahepatic cholestasis.${富文本块}